Virtus Fund Advisers, LLC Veracyte, Inc. Transaction History
Virtus Fund Advisers, LLC
- $20.2 Million
- Q3 2024
A detailed history of Virtus Fund Advisers, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Virtus Fund Advisers, LLC holds 4,798 shares of VCYT stock, worth $194,702. This represents 0.81% of its overall portfolio holdings.
Number of Shares
4,798
Previous 3,609
32.95%
Holding current value
$194,702
Previous $78,000
108.97%
% of portfolio
0.81%
Previous 0.31%
Shares
5 transactions
Others Institutions Holding VCYT
# of Institutions
310Shares Held
81.5MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$316 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$314 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$204 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$200 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$172 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.9B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...